Keywords: icn, 2nd-qtr, revenues, pushing, million, pharmaceuticals, posted
ICN 2nd-qtr revenues pushing $200 million
Article | 07 August 2000
ICN Pharmaceuticals has posted second-quarter revenues of $191 million,up 8%, while net income reached $31 million compared with $26 million in the corresponding ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
